Funding · Company
Gemelli Biotech Corp.
Raleigh, NCBiotech & Pharma
Gemelli Biotech Corp. of Raleigh, NC has disclosed $21M across 1 Form D offering filed with the SEC on Dec 2, 2024.
$21M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$21M
Form D · Dec 2, 2024 ↗
Q4 2024
· 1 amendment, first filed Jun 8, 2022
· target $24M
Filing details
HeadquartersRaleigh, NCIndustryBiotech & Pharma (Biotechnology)SEC CIK0001780605Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →